2020
DOI: 10.1016/j.ultrasmedbio.2020.02.018
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Focused Ultrasound Surgery and Hysteroscopic Resection for Treatment of Submucosal Uterine Fibroids (FIGO Type 2)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
14
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 30 publications
2
14
0
1
Order By: Relevance
“…4). The treatment outcome of this study is also comparable to that of the previous studies (LeBlang et al 2010;Soliman et al 2017;Baggio et al 2018;Hu et al 2020), in which more than 90% of patients had symptom alleviation and fibroid shrinkage. In addition to fibroid shrinkage and USF-QOL, NPV is often used to evaluate HIFU efficacy, and NPVR is recommended to be at least 0.50 (LeBlang et al 2010).…”
Section: Feasibility Of Devascularization and Treatment Outcomesupporting
confidence: 86%
“…4). The treatment outcome of this study is also comparable to that of the previous studies (LeBlang et al 2010;Soliman et al 2017;Baggio et al 2018;Hu et al 2020), in which more than 90% of patients had symptom alleviation and fibroid shrinkage. In addition to fibroid shrinkage and USF-QOL, NPV is often used to evaluate HIFU efficacy, and NPVR is recommended to be at least 0.50 (LeBlang et al 2010).…”
Section: Feasibility Of Devascularization and Treatment Outcomesupporting
confidence: 86%
“…These 10 trials were published between 2009 and 2020 and had sample sizes ranging from 39 to 1353, with a total of 4217 participants. The study designs were 1 RCT [16], 6 prospective studies [10,11,14,15,17,19], and 3 retrospective studies [12,13,18]. All trials recruited patients with uterine myomas.…”
Section: Trial Characteristicsmentioning
confidence: 99%
“…We combined the myomectomy and hysterectomy groups into a surgery group. Four studies evaluated the baseline uterine myoma status on the basis of the number of myomas [11,16,17,19]; 4 studies evaluated the volume (centimeters cubed) of the largest myoma [10,11,13,16]; and 7 studies evaluated the diameter (centimeters) of the largest myoma [11,13,14,16 −19]. The diameter of myoma varied from 3.8 to 10 cm in the HIFU group and 3.6 to 10 cm in the surgery group.…”
Section: Trial Characteristicsmentioning
confidence: 99%
See 1 more Smart Citation
“…About 18 studies were included in the review (12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27). About three were RCTs (16,18,21), seven were non-RCTs (12,15,17,(22)(23)(24)26), and eight were cohort studies (13,14,19,20,25,(27)(28)(29). In Barnard et al (19), only the cohort data were included in the meta-analysis.…”
Section: Study Characteristicsmentioning
confidence: 99%